LC
PDSB icon

Lindbrook Capital’s PDS Biotechnology PDSB Stock Holding History

Lindbrook Capital’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-500
Closed -$2.48K – 2731
2023
Q4 		$2.48K Hold
500
– – ﹤0.01% 2193
2023
Q3 		$2.52K Hold
500
– – ﹤0.01% 2040
2023
Q2 		$2.52K Hold
500
– – ﹤0.01% 2063
2023
Q1 		$3.08K Hold
500
– – ﹤0.01% 2063
2022
Q4 		$6.6K Hold
500
– – ﹤0.01% 1660
2022
Q3 		$1K Hold
500
– – ﹤0.01% 2448
2022
Q2 		$2K Hold
500
– – ﹤0.01% 2024
2022
Q1 		$3K Hold
500
– – ﹤0.01% 1859
2021
Q4 		$4K Buy
+500
New +$5.38K ﹤0.01% 1591

Other funds holding PDSB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Lindbrook Capital's PDSB Position: Q1 2024 in Review

Lindbrook Capital sold out of PDS Biotechnology (PDSB) in Q1 2024, closing a stake of 500 shares — an estimated $2.48K sold.

Lindbrook Capital first reported a position in PDSB in Q4 2021 and held it in 9 quarters. The position peaked at $6.6K in Q4 2022. 72 funds tracked by Wall St. Rank hold PDSB as of Q1 2024.

  • Lindbrook Capital reported no remaining PDS Biotechnology position as of Q1 2024 after selling out during the quarter.
  • Lindbrook Capital sold 500 PDS Biotechnology shares in Q1 2024, an estimated $2.48K.
  • Lindbrook Capital first reported a position in PDS Biotechnology in Q4 2021 and held it in 9 quarters.
  • Lindbrook Capital's PDS Biotechnology position peaked at $6.6K in Q4 2022.
  • 72 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2024.

Based on Lindbrook Capital's 13F filing for Q1 2024, filed 25 Apr 2024.